- The trend backdrop is active with a 7-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
VIMIAN
STO
Week ended 07 Aug 2026
Weekly Investor Report
Vimian Group AB (publ) · Healthcare · Diagnostics & Research
Latest close
35.10 SEK
3.2%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 19.8% above the Trend Line and sits at 94.4% of its 52-week range. The latest completed week returned 3.2%, after a 15.3% four-week move. The latest news-sentiment score is 57/100. Near-term considerations: price is close to its 52-week high; volume confirmation is below normal.
Setup score
59
out of 100
Latest Close
35.10 SEK
7 Aug 2026
1W Return
3.2%
latest completed week
4W Return
15.3%
short-term follow-through
12W Return
16.6%
quarterly tape
Trend Breadth
13.5%
7 of 52 weeks active
Volume Ratio
0.9x
vs 13-week average
- Next-week expectancy is negative at 39.32% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
3.2%
Latest completed week; four-week move 15.3%.
Indicator stack
32/80
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 39.32%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
57/100
19 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 19.8% above the Trend Line and sits at 94.4% of its 52-week range. The latest completed week returned 3.2%, after a 15.3% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.3712-week average 0.29
12-week confirmation
Trend active7/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership4/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.37Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 15.3% over four weeks, 16.6% over 12 weeks, and 10.4% over one year. The current trend has remained active for 7 consecutive weeks.
Performance by holding period
Active trend streak7 weeks
Active weeks in one year7
Trend breadth13.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.33Latest activity-pressure read.
Pressure change78.5%Four-week change in activity pressure.
Leadership4.95Latest relative-leadership reading.
RS change169.1%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment57/100
Weighted news tone is neutral across 19 relevant articles.
6 positive · 11 neutral · 2 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-1.8%Distance below the 52-week high.
13-week volatility3.9%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher15 of 2610 weeks finished lower.
Best week+10.8%Week of 17 Jul.
Worst week-7.9%Week of 24 Apr.
Latest week+3.2%Week of 7 Aug.
Shape of recent returns
Strong gains7
Modest gains8
Flat weeks1
Modest losses6
Sharp losses4
Recent vol3.9%13-week weekly-return volatility.
Base vol4.3%52-week weekly-return volatility.
Up/down split25/26Count of positive and negative weeks in the 52-week window.
Average skew4.1% / -3.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorSE Healthcare
4-week rank9 / 100
Group average-1.1%
Trend breadth39.0%
Trend39.0%active weekly trend signals
MD42.0%positive activity pressure
RS21.0%positive relative leadership
Four-week leaders
IndustrySE Diagnostics & Research
4-week rank1 / 6
Group average-4.1%
Trend breadth50.0%
Trend50.0%active weekly trend signals
MD16.7%positive activity pressure
RS16.7%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape53/100
Trend, activity pressure, participation, and risk combine to a 53/100 tape read.
Indicator analysis57/100Latest 12-week confirmation: trend 7/12, activity pressure 12/12, relative leadership 4/12.
Activity pressure 0.37; No reversal markers Next-Week ExpectancyNegative 39.32%Next-week expectancy is negative with a 39.32% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment57/100Weighted news tone is neutral across 19 relevant articles.
Vimian Group AB Revenue Breakdown – FWB:0V0 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 35.10 SEK | 3.2% | 29.29 SEK | 33.34 SEK | 1.33 | 4.95 | 1.2M | On |
| 31 Jul 2026 | 34.00 SEK | 0.7% | 29.20 SEK | 33.31 SEK | 1.15 | 3.39 | 961.7K | On |
| 24 Jul 2026 | 33.75 SEK | 0.0% | 29.09 SEK | 33.27 SEK | 0.95 | 3.63 | 1.2M | On |
| 17 Jul 2026 | 33.75 SEK | 10.8% | 28.95 SEK | 33.23 SEK | 0.78 | 4.66 | 1.2M | On |
| 10 Jul 2026 | 30.45 SEK | 0.5% | 28.82 SEK | 33.19 SEK | 0.74 | -7.17 | 1.5M | On |
| 3 Jul 2026 | 30.30 SEK | 2.9% | 28.77 SEK | 33.16 SEK | 0.80 | -10.73 | 284.4K | On |
| 26 Jun 2026 | 29.45 SEK | -0.5% | 28.77 SEK | 33.13 SEK | 0.68 | -11.85 | 190.9K | On |
| 19 Jun 2026 | 29.60 SEK | -1.3% | 28.79 SEK | 33.10 SEK | 0.76 | -13.11 | 5.2M | Off |
| 12 Jun 2026 | 30.00 SEK | 6.6% | 28.77 SEK | 33.10 SEK | 0.64 | -11.24 | 1.2M | Off |
| 5 Jun 2026 | 28.15 SEK | 0.7% | 28.79 SEK | 33.11 SEK | 0.64 | -17.72 | 164.7K | Off |
| 29 May 2026 | 27.95 SEK | -4.6% | 28.85 SEK | 33.12 SEK | 0.95 | -19.98 | 2.2M | Off |
| 22 May 2026 | 29.30 SEK | -2.7% | 28.92 SEK | 33.14 SEK | 1.02 | -17.68 | 944.9K | Off |
| 15 May 2026 | 30.10 SEK | -1.8% | 29.00 SEK | 33.13 SEK | 1.01 | -13.32 | 762.0K | Off |
| 8 May 2026 | 30.65 SEK | 1.8% | 28.97 SEK | 33.15 SEK | 1.02 | -13.64 | 1.9M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.